Tuesday, September 02, 2014 12:29:01 PM
One burning question that will be answered in the coming months, will be 'is the patent infringement filing by Antares enough to delay Medacs' entry into the market place? Yes, the CP and TI did not work, but the original "First Complaint" v Medac is still working its way through the legal process with many steps to go through (assuming their is no pending settlement) and also, the "Notice of Appeal by Plaintiff Antares Pharma, Inc" is in process. Will these things give Medac pause to launch, will these things motivate Medac to settle and visa versa??
I don't think any gain from further litigation will be known for a few months. Until then, the wheels of justice, so to speak, are in motion. But ultimately, imo, there will be a settlement between both parties.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM